Mallinckrodt Pharmaceuticals Reaches Tentative $1.6B Opioid Settlement

Mallinckrodt, a major generic drug manufacturer, announced a settlement to resolve lawsuits related to its role in the US opioid crisis. The company will pay $1.6 billion to a trust for opioid crisis costs and will cease marketing opioids. This settlement, approved by 47 states, aims to provide relief to victims and prevent future issues. In 2010, a subsidiary shipped 210 million doses of oxycodone to Florida, highlighting the scale of the crisis.

What new insight or understanding did you gain from this video?